The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Proxy Biomedical sales in the US from 2017 to 2023, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Smarter leaders trust GlobalData
Proxy Biomedical Ltd (Proxy Biomedical) is a medical device company that research, develops and manufactures biomaterials for medical implant products. The company offers products for hernia repair such as macroporous PTFE Hernia, macroporous pp surgical mesh; and a lightweight condensed polypropylene mesh. It provides blue lightweight macroporous pp surgical mesh an implant suitable for different types of facial defects. Proxy Biomedical’s offers macroporous PTFE with a Star-motif macro-porous structure to optimise tissue integration and healing. The company’s technologies are used in the areas of general surgery, orthopaedics, pelvic health, and cardiovascular sectors. It markets products through its network of distributors in Ireland. It also partners with other medical device companies. Proxy Biomedical is headquartered in Galway, Connacht, Ireland. Key subsidiaries of Proxy Biomedical include Viscus Biologics.
The key metrics of Proxy Biomedical related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2023 are shown below:
As Proxy Biomedical is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Proxy Biomedical.
For a detailed understanding of the performance of Proxy Biomedical, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.
